Why did Trump end trade talks with Canada?
How will Supreme Court birthright ruling impact business?
Why is Nike's stock soaring despite revenue slump?
What caused Nvidia's stock to hit record highs?
How did US-China trade deal affect markets?
Why did Tesla's robotaxi launch face issues?
What are the concerns with AI in Trump’s megabill?
Altimmune's Fatty Liver Candidate Faces Differentiation Doubts
benzinga.com/analyst-stock-ratings/analyst-color/25/06/46149812/altimmunes-fatty-liver-candidate-faces-differentiation-doubts
On Thursday, Altimmune, Inc. (NASDAQ:ALT) released topline results from the IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH).
MASH is a severe liver disease characterized by fat buildup and inflammation in the liver, which can lead to…
This story appeared on benzinga.com, 2025-06-27 18:39:38.